# Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema

> **NCT01306513** · PHASE1 · COMPLETED · sponsor: **Leiden University Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Emphysema

## Interventions

- **BIOLOGICAL:** autologous bone marrow derived mesenchymal stromal cells

## Key facts

- **NCT ID:** NCT01306513
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-06
- **Final completion:** 2012-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306513, "Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01306513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*